Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 3,768 | 4,048 | 3,848 | 4,367 | 8,195 |
| Operating Income | -3,768 | -4,048 | -3,848 | -4,367 | -8,195 |
| Interest Expense | 0 | 0 | 0 | -231 | 0 |
| Other Income | 137 | 180 | 431 | 0 | 259 |
| Pre-tax Income | -3,631 | -3,868 | -3,417 | -4,136 | -7,936 |
| Income Tax | N/A | N/A | N/A | -55 | 34 |
| Net Income Continuous | -3,631 | -3,868 | -3,417 | -4,081 | -7,970 |
| Net Income | $-3,631 | $-3,868 | $-3,417 | $-4,081 | $-7,970 |
| EPS Basic Total Ops | -1.04 | -1.12 | -0.80 | -1.36 | -2.88 |
| EPS Basic Continuous Ops | -1.02 | -1.09 | -0.82 | -1.38 | -2.88 |
| EPS Diluted Total Ops | -1.04 | -1.12 | -0.80 | -1.36 | -2.88 |
| EPS Diluted Continuous Ops | -1.02 | -1.09 | -0.82 | -1.38 | -2.88 |
| EPS Diluted Before Non-Recurring Items | -1.04 | -1.12 | -1.04 | N/A | N/A |
| EBITDA(a) | $-3,768 | $-4,048 | $-3,832 | $-4,348 | $-8,179 |